ArticleContemporary clinical trials2025

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.

Ekaterina V Kurbatova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.